- Human pathology

Home > E. Pathology by systems > Reproductive system > Female genital system > Breast > prosigna test

prosigna test

Monday 17 October 2016



Open references

- The effects of lymph node status on predicting outcome in ER+ /HER2- tamoxifen treated breast cancer patients using gene signatures. Cockburn JG, Hallett RM, Gillgrass AE, Dias KN, Whelan T, Levine MN, Hassell JA, Bane A. BMC Cancer. 2016 Jul 28;16:555. doi : 10.1186/s12885-016-2501-0
PMID: 27469239 Free

- Retrospective analysis of molecular scores for the prediction of distant recurrence according to baseline risk factors. Sestak I, Dowsett M, Ferree S, Baehner FL, Cuzick J. Breast Cancer Res Treat. 2016 Aug;159(1):71-8.
doi : 10.1007/s10549-016-3868-y PMID: 27447876 Free

- Development and verification of the PAM50-based Prosigna breast cancer gene signature assay. Wallden B, Storhoff J, Nielsen T, Dowidar N, Schaper C, Ferree S, Liu S, Leung S, Geiss G, Snider J, Vickery T, Davies SR, Mardis ER, Gnant M, Sestak I, Ellis MJ, Perou CM, Bernard PS, Parker JS. BMC Med Genomics. 2015 Aug 22;8:54. doi : 10.1186/s12920-015-0129-6
PMID: 26297356 Free